|
| Bank | Number of donors/number of grafts processed annually (Average) | Proportion of products meeting release criteria | Reasons for product failure | Proportion of released products implanted | Reasons released products are not implanted |
|
| E1 | 45 donors
75 valves | ~79% | (1) Abnormal morphology of graft
(2) Positive microbiological results of graft
(3) Positive serology results of donor | 99.5% | Decision during surgery |
|
| E2 | 25 donors
40 valves | ~70% | (1) Failure in valve competency
(2) Positive microbiological results of graft
(3) Technical issues | 95% | Decision during surgery |
|
| E3 | 97 grafts | ~50% | Positive microbiological results | 95% | (1) Size demands for valves
(2) Low demand for type of valve |
|
| E4 | 72 donors
80 valves
130 patches | 90% | (1) Failure in valve competency (primarily aortic valves)
(2) Positive microbiological results of graft | 98% | Decision during surgery, cancellation of surgery |
|
| E5 | 4 donors
8 valves | ~69% | (1) Positive microbiological results of graft
(2) Positive serology results of donor | 100% | NA |
|
| E6 | 35 donors
30 valves | ~70% | Positive microbiological results of graft | 95% | Low demand for aortic valves |
|
| E7 | 20–30 donors
50 valves | ~90% | (1) Positive microbiological results of graft
(2) Technical issues | 60% | Size demand for valves—a congenital cardiac centre only |
|
| E8 | 40–50 donors
80 valves | ~80% | Positive microbiological results of graft | 95% | (1) Size demand for valves
(2) Beyond maximum storage duration of patch graft |
|
| E9 | 300 donors
400 valves | ~50% | (1) Abnormal morphology of graft
(2) Positive microbiological results of graft
(3) Technical issues | 85% (100% for pulmonary valves and arterial allografts) | (1) Aortic valve size
(2) Low demand for aortic valves
(3) Decision during surgery
(4) Damage of graft during thawing |
|
| E10 | 100 donors
250 grafts | ~68% | Abnormal morphology of graft | 65% | Size demand for valves |
|
| E11 | 217 donors
380 valves | ~78% | (1) Abnormal morphology of graft
(2) Positive microbiological results of graft | 84% | (1) Size demand for valves
(2) Low demand for aortic valves |
|
